---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-024633"
form_type: "8-K"
ticker: "XFOR"
cik: "0001501697"
company_name: "X4 Pharmaceuticals, Inc"
filed_at: "2024-05-22T23:59:59+00:00"
generated_at: "2026-06-01T09:43:27.459846+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# X4 Pharmaceuticals files corporate presentation with no specific material updates provided

## Summary
- Filing includes a corporate presentation dated May 22, 2024, but full content not available for analysis.
- No new financial or clinical data points are discernible from the limited exhibit excerpt.
- The presentation appears to be a routine investor deck; no actionable events reported.

## SEC filing metadata
- accession: 0001628280-24-024633
- form_type: 8-K
- ticker: XFOR
- cik: 0001501697
- company_name: X4 Pharmaceuticals, Inc
- filed_at: 2024-05-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501697/000162828024024633/0001628280-24-024633-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501697/000162828024024633/xfor-20240522.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-024633
- JSON: https://secwatch.observer/filing/0001628280-24-024633.json
- Plain text: https://secwatch.observer/filing/0001628280-24-024633.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.